Nebenwirkungen · Etcamah
Etcamah 75 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 10
HOS-153285 · Präparat HOS-100955
Electrocardiogram QT Common Common prolongedl a. Graded according to National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE), version 5.0. b. Visual effects include photopsia, vision blurred, visual impairment, diplopia, and photophobia of eye disorders MedDRA SOC, and visual perseveration of nervous system disorders MedDRA SOC. In addition to camizestrant, vision blurred is an ADR for palbociclib and photopsia is an ADR for abemaciclib. c. Bradycardia includes bradycardia and sinus bradycardia. d. All PTs under the Infections and Infestation SOC. e. ADR for camizestrant and palbociclib combination. f. ADR for camizestrant and abemaciclib combination. g. ADR for camizestrant and ribociclib combination. h. Neutropenia includes neutropenia and neutrophil count decreased. i. Anaemia includes anaemia, anaemia macrocytic and iron deficiency anaemia. j. Leukopenia includes leukopenia and white blood cell count decreased. k. Thrombocytopenia includes thrombocytopenia and platelet count decreased.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-21T14:07:16Z · SHA-256 b50ea6ed7223cee8c2b96a46475d89e0843fb8c57083f80f60c2957e00e303a8 · Passage 8898dcda22a46e204cea0aade214df111b550c90f37b6eedf8bf7b4ea8c595ec · Zeichen 7113–8320 im Abschnitt